Delcath Systems, a medical technology company specializing in cancer treatment, has appointed Eamonn Hobbs to its board of directors.
Subscribe to our email newsletter
Mr Hobbs is president and CEO of AngioDynamics, a medical device company specializing in the development and sales of medical technology serving the needs of interventional oncologists and vascular interventionalists.
Richard Taney, president and CEO of Delcath, said: “We are delighted to have Eamonn join the board of directors of Delcath. His successful leadership of AngioDynamics, his experience within the medical device industry and his involvement in a number of medical organizations make him a welcome addition to our board of directors.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.